Stay updated on SNDX-5613 with Chemo in AML Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 with Chemo in AML Clinical Trial page.

Latest updates to the SNDX-5613 with Chemo in AML Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer software version/implementation label updates from “Revision: v3.5.2” to “Revision: v3.5.3” without reflecting any participant or trial-record content changes.SummaryDifference0.0%

- Check8 days agoChange DetectedAdded updates for Study Status and Contacts/Locations dated 2026-04-14 and 2026-04-15, introducing entries 113–115. The record revision was updated to v3.5.2, replacing v3.5.0.SummaryDifference0.4%

- Check16 days agoChange DetectedNew history entries document recent Study Status updates (versions 109–112) with corresponding dates.SummaryDifference0.5%

- Check23 days agoChange DetectedNew Study Status entries were added for 2026-04-01 to 2026-04-03, updating the study's history with recent status changes.SummaryDifference0.6%

- Check30 days agoChange DetectedNew Study Status entries were added to the Record History (dates 2026-03-21 to 2026-03-27). This expands the history of the study's status updates.SummaryDifference0.7%

- Check37 days agoChange DetectedAdded Study Status and Contacts/Locations sections to the history page, with new revision entries up to v3.5.0 (revisions 97–94).SummaryDifference0.7%

Stay in the know with updates to SNDX-5613 with Chemo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 with Chemo in AML Clinical Trial page.